Form 8-K - Current report:
SEC Accession No. 0001558370-25-001553
Filing Date
2025-02-26
Accepted
2025-02-26 07:02:12
Documents
14
Period of Report
2025-02-26
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rytm-20250226x8k.htm   iXBRL 8-K 31682
2 EX-99.1 rytm-20250226xex99d1.htm EX-99.1 249142
  Complete submission text file 0001558370-25-001553.txt   421384

Data Files

Seq Description Document Type Size
3 EX-101.SCH rytm-20250226.xsd EX-101.SCH 3420
4 EX-101.LAB rytm-20250226_lab.xml EX-101.LAB 15926
5 EX-101.PRE rytm-20250226_pre.xml EX-101.PRE 10324
16 EXTRACTED XBRL INSTANCE DOCUMENT rytm-20250226x8k_htm.xml XML 4857
Mailing Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116
Business Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116 857-264-4280
RHYTHM PHARMACEUTICALS, INC. (Filer) CIK: 0001649904 (see all company filings)

EIN.: 462159271 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38223 | Film No.: 25666092
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)